{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:32:55Z","timestamp":1790721175335,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_197557"],"award-info":[{"award-number":["310030_197557"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030-236150"],"award-info":[{"award-number":["320030-236150"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Swiss Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Foundation for Medical and Biological Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Scientific Research"},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013161","name":"Swiss Life Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013161","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kurt und Senta-Hermann Stiftung"},{"DOI":"10.13039\/501100008464","name":"EMDO Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008464","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Schweizerische Diabetes-Stiftung"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-coding RNA (ncRNA), including microRNA, long non-coding RNA, and circular RNA, are epigenetic signals acting as upstream regulators in several cardiovascular disease processes. This review explores how ncRNA profiling complements non-invasive cardiac imaging modalities by providing biological insights into structural and functional phenotypes. In conditions such as hypertensive heart disease and aortic stenosis, ncRNAs like microRNA (miR)-29 and miR-155 correlate with left ventricular hypertrophy and fibrosis. In dilated cardiomyopathy and heart failure, circulating miR-150\u20135p, miR-21, and LIPCAR associate with disease severity and prognosis beyond well-established echocardiographic prognosticators. Post-infarction remodelling has been linked to dynamic changes in miR-155, miR-143, and miR-150, while atrial disease and atrial fibrillation progression are reflected in distinct miRNA profiles. In valve disease, miR-206 levels mirror functional recovery after transcatheter aortic valve implantation, while they associate with right-ventricular dysfunction in the setting of pulmonary hypertension. Cardiac MRI studies have shown that ncRNA such as miR-29a and has-Chr8:96 may distinguish pathologies including hypertrophic cardiomyopathy and myocarditis. In nuclear imaging, circ-MBOAT2 and miR-495 correlate with myocardial perfusion in chronic total occlusion, and exosomal miRNA may support functional stratification. CT imaging may also benefit from ncRNA biomarkers such as miR-3154 in vascular disease. Despite promises, standardization and prospective validation remain crucial for clinical translation. Taken together, ncRNA enrich imaging phenotypes by illuminating molecular underpinnings, enhancing prognostication, and offering potential targets for personalized cardiovascular care.<\/jats:p>","DOI":"10.1093\/ehjimp\/qyaf166","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T12:32:50Z","timestamp":1767357170000},"source":"Crossref","is-referenced-by-count":3,"title":["Seeing and sensing the heart: integrating non-coding RNA biomarkers with imaging in cardiovascular medicine"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-4930","authenticated-orcid":false,"given":"Jan Alphard","family":"Kleeberger","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Heart Center; University Hospital Zurich , Zurich CH-8091 ,","place":["Switzerland"]},{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich , Wagistrasse 12, 8952 Schlieren, Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1941-6938","authenticated-orcid":false,"given":"Ludovica","family":"Di Venanzio","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center; University Hospital Zurich , Zurich CH-8091 ,","place":["Switzerland"]},{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich , Wagistrasse 12, 8952 Schlieren, Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7793-7082","authenticated-orcid":false,"given":"Natalia","family":"Atzemian","sequence":"additional","affiliation":[{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich , Wagistrasse 12, 8952 Schlieren, Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-0596","authenticated-orcid":false,"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center; University Hospital Zurich , Zurich CH-8091 ,","place":["Switzerland"]},{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich , Wagistrasse 12, 8952 Schlieren, Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-7844","authenticated-orcid":false,"given":"Francesco","family":"Paneni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center; University Hospital Zurich , Zurich CH-8091 ,","place":["Switzerland"]},{"name":"Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich , Wagistrasse 12, 8952 Schlieren, Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026012210112770700_qyaf166-B1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026012210112770700_qyaf166-B2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jacc.2021.08.022","article-title":"Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week","volume":"78","author":"Patel","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026012210112770700_qyaf166-B3","doi-asserted-by":"crossref","first-page":"e017567","DOI":"10.1161\/CIRCIMAGING.124.017567","article-title":"Temporal trends in noninvasive and invasive cardiac testing from 2010 to 2022 in the US medicare population","volume":"18","author":"Cohen","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012210112770700_qyaf166-B4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026012210112770700_qyaf166-B5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41569-024-01001-5","article-title":"Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease","volume":"21","author":"Caporali","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026012210112770700_qyaf166-B6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"ENCODE Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2026012210112770700_qyaf166-B7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026012210112770700_qyaf166-B8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrg3561","article-title":"Non-coding RNA: structure and function for lncRNAs","volume":"14","author":"Flintoft","year":"2013","journal-title":"Nat Rev Genet"},{"key":"2026012210112770700_qyaf166-B9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/eurheartj\/ehy903","article-title":"Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy","volume":"40","author":"Costantino","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012210112770700_qyaf166-B10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41569-022-00680-2","article-title":"Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease","volume":"19","author":"Santovito","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026012210112770700_qyaf166-B11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/dc23-0012","article-title":"Circulating long noncoding RNA signatures associate with incident diabetes in older adults: a prospective analysis from the VITA cohort study","volume":"46","author":"Wenzl","year":"2023","journal-title":"Diabetes Care"},{"key":"2026012210112770700_qyaf166-B12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCRESAHA.124.325196","article-title":"LncRNA MIR181A1HG deficiency attenuates vascular inflammation and atherosclerosis","volume":"136","author":"Ni","year":"2025","journal-title":"Circ Res"},{"key":"2026012210112770700_qyaf166-B13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCRESAHA.123.323356","article-title":"Therapeutic inhibition of LincRNA-p21 protects against cardiac hypertrophy","volume":"135","author":"Wang","year":"2024","journal-title":"Circ Res"},{"key":"2026012210112770700_qyaf166-B14","doi-asserted-by":"crossref","first-page":"e147031","DOI":"10.1172\/JCI147031","article-title":"Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation","volume":"131","author":"Gong","year":"2021","journal-title":"J Clin Invest"},{"key":"2026012210112770700_qyaf166-B15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2020.0871","article-title":"Efficiency and target derepression of anti-miR-92a: results of a first in human study","volume":"30","author":"Abplanalp","year":"2020","journal-title":"Nucleic Acid Ther"},{"key":"2026012210112770700_qyaf166-B16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012210112770700_qyaf166-B17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012210112770700_qyaf166-B18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/10641963.2016.1226889","article-title":"Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy","volume":"39","author":"Huang","year":"2017","journal-title":"Clin Exp Hypertens"},{"key":"2026012210112770700_qyaf166-B19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/10641963.2015.1116551","article-title":"Circulating miR155 expression level is positive with blood pressure parameters: potential markers of target-organ damage","volume":"38","author":"Huang","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"2026012210112770700_qyaf166-B20","doi-asserted-by":"crossref","first-page":"40696","DOI":"10.1038\/srep40696","article-title":"MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure","volume":"7","author":"Beaumont","year":"2017","journal-title":"Sci Rep"},{"key":"2026012210112770700_qyaf166-B21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41598-018-28246-8","article-title":"MicroRNAs distribution in different phenotypes of aortic stenosis","volume":"8","author":"Fabiani","year":"2018","journal-title":"Sci Rep"},{"key":"2026012210112770700_qyaf166-B22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjopen\/oeae060","article-title":"Role of myocardial microRNAs in the long-term ventricular remodelling of patients with aortic stenosis","volume":"4","author":"Gabriel","year":"2024","journal-title":"Eur Heart J Open"},{"key":"2026012210112770700_qyaf166-B23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41598-019-56617-2","article-title":"Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy","volume":"9","author":"Sonnenschein","year":"2019","journal-title":"Sci Rep"},{"key":"2026012210112770700_qyaf166-B24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BSR20191234","article-title":"MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy","volume":"40","author":"Huang","year":"2020","journal-title":"Biosci Rep"},{"key":"2026012210112770700_qyaf166-B25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41598-021-87086-1","article-title":"Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy","volume":"11","author":"Calderon-Dominguez","year":"2021","journal-title":"Sci Rep"},{"key":"2026012210112770700_qyaf166-B26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00109-021-02119-6","article-title":"Circulating circRNA as biomarkers for dilated cardiomyopathy etiology","volume":"99","author":"Costa","year":"2021","journal-title":"J Mol Med"},{"key":"2026012210112770700_qyaf166-B27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2017.02.008","article-title":"Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: a genome-wide prospective study","volume":"36","author":"Scrutinio","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026012210112770700_qyaf166-B28","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.118.12261","article-title":"Circulating long noncoding RNA LIPCAR predicts heart failure outcomes in patients without chronic kidney disease","volume":"73","author":"Santer","year":"2019","journal-title":"Hypertension"},{"key":"2026012210112770700_qyaf166-B29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00380-024-02410-9","article-title":"Plasma microRNA-143 and microRNA-145 levels are elevated in patients with left ventricular dysfunction","volume":"39","author":"Murase","year":"2024","journal-title":"Heart Vessels"},{"key":"2026012210112770700_qyaf166-B30","first-page":"7","article-title":"Correlation between serum levels of microRNA-21 and inflammatory factors in patients with chronic heart failure","volume":"101","author":"Li","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2026012210112770700_qyaf166-B31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000477235","article-title":"Failed downregulation of circulating MicroRNA-155 in the early phase after ST elevation myocardial infarction is associated with adverse left ventricular remodeling","volume":"138","author":"Latet","year":"2017","journal-title":"Cardiology"},{"key":"2026012210112770700_qyaf166-B32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1536\/ihj.18-306","article-title":"Serum circulating miR-150 is a predictor of post-acute myocardial infarction heart failure","volume":"60","author":"Lin","year":"2019","journal-title":"Int Heart J"},{"key":"2026012210112770700_qyaf166-B33","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1253\/circj.CJ-22-0698","article-title":"An increase in plasma MicroRNA-143 levels in the acute phase is positively correlated with recovery of cardiac function in the chronic phase in patients with acute myocardial infarction","volume":"87","author":"Satake","year":"2023","journal-title":"Circ J"},{"key":"2026012210112770700_qyaf166-B34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1371\/journal.pone.0148599","article-title":"MicroRNAs as biomarkers for acute atrial remodeling in marathon runners (the miRathon study - A sub-study of the Munich marathon study)","volume":"11","author":"Clauss","year":"2016","journal-title":"PLoS One"},{"key":"2026012210112770700_qyaf166-B35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.pone.0236960","article-title":"Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: data from the framingham offspring study","volume":"15","author":"Vaze","year":"2020","journal-title":"PLoS One"},{"key":"2026012210112770700_qyaf166-B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.pone.0283942","article-title":"Circulating miR-20b-5p and miR-330-3p are novel biomarkers for progression of atrial fibrillation: intracardiac\/extracardiac plasma sample analysis by small RNA sequencing","volume":"18","author":"Harada","year":"2023","journal-title":"PLoS One"},{"key":"2026012210112770700_qyaf166-B37","doi-asserted-by":"crossref","first-page":"H1261","DOI":"10.1152\/ajpheart.00432.2017","article-title":"microRNA-206 correlates with left ventricular function after transcatheter aortic valve implantation","volume":"313","author":"Kleeberger","year":"2017","journal-title":"Am J Physiol-Heart Circul Physiol"},{"key":"2026012210112770700_qyaf166-B38","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1161\/CIRCULATIONAHA.122.060258","article-title":"Circulating MicroRNA-122-5p is associated with a lack of improvement in left ventricular function after transcatheter aortic valve replacement and regulates viability of cardiomyocytes through extracellular vesicles","volume":"146","author":"Hosen","year":"2022","journal-title":"Circulation"},{"key":"2026012210112770700_qyaf166-B39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5603\/CJ.a2022.0090","article-title":"Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation","volume":"31","author":"Eyileten","year":"2024","journal-title":"Cardiol J"},{"key":"2026012210112770700_qyaf166-B40","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1159\/000475569","article-title":"The circulating MicroRNA-206 level predicts the severity of pulmonary hypertension in patients with left heart diseases","volume":"41","author":"Jin","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2026012210112770700_qyaf166-B41","doi-asserted-by":"crossref","first-page":"e004862","DOI":"10.1161\/CIRCGEN.124.004862","article-title":"Diagnostic MicroRNA signatures to support classification of pulmonary hypertension","volume":"18","author":"Errington","year":"2025","journal-title":"Circ Genom Precis Med"},{"key":"2026012210112770700_qyaf166-B42","doi-asserted-by":"crossref","first-page":"105284","DOI":"10.1016\/j.cmpb.2019.105284","article-title":"Ultrasonic cardiogram and MiRNA-21 analysis of cardiac dysfunction in patients with cardiac arrest following cardiopulmonary resuscitation","volume":"190","author":"Liu","year":"2020","journal-title":"Comput Meth Programs Biomed"},{"key":"2026012210112770700_qyaf166-B43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12968-023-00950-z","article-title":"Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update","volume":"25","author":"von Knobelsdorff-Brenkenhoff","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026012210112770700_qyaf166-B44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/ehjci\/jeae154","article-title":"Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis","volume":"25","author":"Kravchenko","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012210112770700_qyaf166-B45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2024.04.062","article-title":"Association of adverse clinical outcomes with peri-infarct ischemia detected by stress cardiac magnetic imaging","volume":"84","author":"Bernhard","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026012210112770700_qyaf166-B46","doi-asserted-by":"crossref","first-page":"qyaf066","DOI":"10.1093\/ehjimp\/qyaf066","article-title":"Cardiovascular imaging in 2024: review of current research and innovations","volume":"3","author":"Barison","year":"2025","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026012210112770700_qyaf166-B47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012210112770700_qyaf166-B48","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3389\/fphys.2018.01770","article-title":"Identification of cardiomyopathy-associated circulating miRNA biomarkers in muscular dystrophy female carriers using a complementary cardiac imaging and plasma profiling approach","volume":"9","author":"Florian","year":"2018","journal-title":"Front Physiol"},{"key":"2026012210112770700_qyaf166-B49","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1002\/jmri.26611","article-title":"State of the art: evaluation and prognostication of myocarditis using cardiac MRI","volume":"49","author":"Gannon","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"2026012210112770700_qyaf166-B50","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa2003608","article-title":"A novel circulating MicroRNA for the detection of acute myocarditis","volume":"384","author":"Blanco-Dom\u00ednguez","year":"2021","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal - Imaging Methods and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjimp\/advance-article-pdf\/doi\/10.1093\/ehjimp\/qyaf166\/66316890\/qyaf166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/1\/qyaf166\/66316890\/qyaf166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/1\/qyaf166\/66316890\/qyaf166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:11:44Z","timestamp":1769094704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjimp\/article\/doi\/10.1093\/ehjimp\/qyaf166\/8417724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjimp\/qyaf166","relation":{},"ISSN":["2755-9637"],"issn-type":[{"value":"2755-9637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1,1]]},"article-number":"qyaf166"}}